Get the app
NSE › Healthcare

FDC Limited (FDC)

NSE · Healthcare · Drug Manufacturers - Specialty & Generic

₹389.95-0.37%
Last close · 2026-11-06

Latest quarter · ended 2026-09-30

Revenue
₹572 cr
Revenue YoY
+21.0%
Net profit
₹49 cr
Profit YoY
+72.9%
Net margin
8.6%

Key statistics

Market cap
₹6,365 cr
P/E
20.3
Forward P/E
12.0
P/B
2.37
Book value
₹163.75
EPS (TTM)
₹19.24
52-week high
₹442.00
52-week low
₹312.95
50-day MA
₹347.10
200-day MA
₹369.89
Beta
0.11

Analyst view

with an average price target of ₹350.00.

Shareholding

Promoters
69.66%
Institutions
8.17%

Largest named holders

HolderStake
ICICI Prudential Smallcap Fund2.91%
Nippon Life India Trustee Ltd-a/c Nippon India Small Cap Fund2.63%

Recent filings & reports

DocumentDate
Annual report FY2026
FDC LIMITED – ANNUAL REPORT 2025-26 SUMMARY HEADLINE NUMBERS • Revenue from Operations: ₹2,17,093.32 lakhs (FY 2024-25: ₹2,10,812.04 lakhs) – growth
2026-09-01
Quarterly results · Q1 FY27
FDC LIMITED – Q1 FY2027 FINANCIAL SUMMARY --- HEADLINE NUMBERS • Standalone Revenue from Operations (Q1 FY2027): Rs. 35,510 lakhs • Standalone Prof
2026-08-05
Quarterly results · Q4 FY26
FDC LIMITED – Q4 & FY26 RESULTS SUMMARY HEADLINE NUMBERS • Q4 FY26 Revenue: Rs. 585 crores, up 18.9% Y-o-Y • FY26 Revenue: Rs. 2,171 crores, up 3.0%
2026-05-27
Quarterly results · Q3 FY26
FDC LIMITED Q3 FY26 RESULTS SUMMARY --- HEADLINE NUMBERS • Q3 FY26 Revenue: Rs. 465 crores, up 0.1% Y-o-Y (essentially flat) • 9M FY26 Revenue: Rs.
2026-02-05
Quarterly results · Q2 FY26
FDC LIMITED – FINANCIAL SUMMARY FOR RETAIL INVESTORS HEADLINE NUMBERS • Q2 FY2026 Standalone Revenue from Operations: ₹8,178.19 lakhs (vs ₹8,222.81
2025-11-05
Annual report FY2025
FDC LIMITED – ANNUAL REPORT 2024-25 SUMMARY HEADLINE NUMBERS • Revenue from Operations: ₹2,07,011.19 lakhs (FY25) • Total Income (Consolidated): ₹2,
2025-08-29
Quarterly results · Q1 FY26
FDC LIMITED – FINANCIAL RESULTS SUMMARY Q1 FY2025-26 (Quarter Ended June 30, 2025) --- HEADLINE NUMBERS STANDALONE RESULTS • Revenue from operation
2025-08-07
Quarterly results2025-07-16

Readable in the app.

Corporate actions

ActionDetailDate
Dividend₹5 / share
ex-date Feb 11, 2026
2026-02-11

Deals & corporate news

AnnouncementDate
Public announcement of share buyback
FDC Limited has announced a share buyback, subject to required regulatory approvals. It plans to purchase up to 24 lakh fully paid equity shares through the stock-exchange tender-offer mecha
2026-10-29
Board resolution approved buyback of fully paid-up equity shares
FDC’s board approved a share buyback of up to 2.4 million fully paid equity shares, equal to 1.47% of the company’s outstanding shares. The offer price is ₹500 per share, with a maximum tota
2026-10-28
Record date announced for the share buyback
FDC Limited’s board approved its unaudited standalone and consolidated financial results for the quarter and six months ended September 30, 2026. The results received a limited review from t
2026-10-27
Interim Dividend of Rs. 5 per equity share declared
FDC Limited's board of directors announced an interim dividend of Rs. 5 per equity share on February 5, 2026. What happened: The company declared an interim dividend, which is a distributio
2026-02-05

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for FDC Limited — free to start.

Open in the appGoogle PlayApp Store

Other Healthcare companies

Data updated 2026-11-07.